Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now small index

Latent Autoimmune Diabetes in Adult (LADA) clinical trials

1 of 1 indexed Latent Autoimmune Diabetes in Adult (LADA) trials are currently recruiting.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Latent Autoimmune Diabetes in Adult (LADA): 1 US clinical trial tracked, 1 recruiting.

Latent Autoimmune Diabetes in Adult (LADA) is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. The most active sponsor is Yale University, running 1 of these trials.

Enrollment posture brief

Registry condition latent-autoimmune-diabetes-in-adult-lada

OPEN 1 | RECR 100% | LATE 0 | EARLY 0 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Latent Autoimmune Diabet (this)Latent Autoimmune Diabet (th…100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Latent Autoimmune Diabetes in Adult (LADA)

Latent Autoimmune Diabetes in Adult (LADA) lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Latent Autoimmune Diabetes in Adult (LADA) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Latent Autoimmune Diabetes in Adult (LADA) is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase Distribution

Phase data not available

Top Sponsors

Yale University 1 trials

Named interventions

Most-linked intervention names on Latent Autoimmune Diabetes in Adult (LADA) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Self-monitoring Behavioral
1 trials
Exercise program Behavioral
1 trials

US sites by state

Facility locations filed on Latent Autoimmune Diabetes in Adult (LADA) trials. A trial with sites in several states counts in each.

Connecticut 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Latent Autoimmune Diabetes in Adult (LADA) page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Latent Autoimmune Diabetes in Adult (LADA) trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Yale University sponsors the most Latent Autoimmune Diabetes in Adult (LADA) trials on record, review their full trial history before evaluating a specific study. See Yale University's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Latent Autoimmune Diabetes in Adult (LADA) condition card totals 1 registered trials; most-linked intervention Self-monitoring; top US site state Connecticut. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.